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Summary   
 
Determining the etiology of invasive fungal infections (IFI) is critical for patient 
management as fungi vary in their susceptibility to antifungals. However, the etiology  
remains obscure in many cases due to negative culture results. The identification of fungal 
DNA from pathology blocks by PCR and sequencing is an alternative approach to 
determine the etiology of IFI. Previous studies identified fungal DNA in only 50% of 
samples with positive histopathology, probably due to DNA damage by the tissue fixation.  
We used realtime PCR to quantify human and fungal DNA from Formalin-fixed, paraffin 
embedded tissue specimens in order to study the effect of thermal energy during 
extraction on the yield of amplifiable DNA and subsequent identification of fungal DNA.  
Tissue sections from eight patients with proven IFI were subjected to DNA extraction with 
varying exposure to thermal energy. Amplifiable DNA increased up to 76-fold by increasing 
incubation temperature from 65°C to 90°C. An additional increase was documented by 
incubation for up to 6 hours at 90°C. The augmented amplification of fungal DNA was 
associated with improved species identification by sequencing of the PCR amplicons. This 





The identification of fungal pathogens is of major importance for the management of 
patients with invasive fungal infections (IFI), as different fungi have different in vitro 
susceptibilities to antifungal agents. Standard techniques, such as culture and 
histopathology fail to identify causative fungi in many patients, limiting our knowledge of 
the etiology of IFI´s [1,2]. The failure to identify fungi to the species level leads to 
suboptimal empiric antifungal therapies, and management of patients can be particularly 
challenging with progressive disease under standard therapy.  
Molecular methods are an attractive approach to enhance the diagnosis of fungal 
infections, such as through PCR and sequencing of fungal rRNA genes to identify fungi in 
formalin fixed, paraffin embedded (FFPE) tissue specimens. These samples are stored in 
pathology archives and involved tissue can be assayed to reveal the epidemiology of 
fungal infections over many years, if the DNA can be retrieved. However, DNA 
amplification from FFPE specimens can be challenging as evidenced by lower rates of 
fungal identification compared to fresh tissue samples [3,4]. Modification of DNA during 
fixation is thought to explain the poor performance of PCR. Several techniques have been 
studied in order to reverse DNA modification by the fixation procedure. Applying thermal 
energy to samples during DNA extraction increased the amount of amplifiable human DNA 
from FFPE tissue specimens [5]. Fungi with their thick cell walls may impede the 
penetration of fixatives or water and change this dynamic.  
We studied the impact of the application of thermal energy during DNA extraction on the 
amplification of fungal DNA from FFPE tissue samples obtained from patients with proven 
IFI. Subsequent fungal identification was performed by sequencing the amplicons 
produced by broad-range fungal PCR assays. 
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Materials and Methods 
 
The study was approved by the institutional review board of the Fred Hutchinson Cancer 
Research Center (track number 5841, substudy 18) and the University Hospital Frankfurt 
(Main), Germany (track number 375/10). 
 
Patient samples: Tissue samples from patients with proven IFI, e.g. with documentation 
of fungal elements in tissue samples, were identified in the tissue bank of the University 
Hospital Frankfurt. Culture results of the samples were not available. FFPE tissue blocks 
from eight patients were studied (table 1). Aliquots of four sections, 5 µm each, were cut 
from tissue blocks and placed in Eppendorf Biopur® tubes (Eppendorf AG, Hamburg, 
Germany) for DNA extraction. The first and the last section from each block were placed 
on slides and stained by Grocott´s methenamine silver stain to document fungal 
structures.  
 
DNA Extraction: After paraffin removal using octane, DNA was extracted using the 
MasterPure™ Yeast DNA Purification Kit (Epicentre® Biotechnologies, Madison, WI) with 
an additional bead beating step to optimise fungal cell lysis as described previously [6]. 
This kit utilizes a non enzymatic approach to lyse fungal cell walls at 65°C. Contaminating 
macromolecules were then removed by a precipitation step, followed by DNA precipitation 
with isopropanol for purification of DNA. Extracted DNA was dissolved in 75 µl of 0,5% 
Triton X and stored at -20°C until PCR testing.  
In order to evaluate the effect of thermal energy on the amount of amplifiable DNA, two 
modifications of the previously described protocol were studied.  First, the initial incubation 
step in lysis buffer was carried out at either 65°C, as proposed by the manufacturer, or at 
90°C for one hour with aliquots of all samples. Second, the duration of incubation at 90°C 
was increased from one hour to three, six and twelve hours using the samples 1,4,6 and 7  
in duplicate extractions.    
 
Quantification of DNA: Real-time PCR was performed with an Applied Biosystems 
7500™ instrument. Human DNA was quantified using a PCR assay targeting a 155 base 
pair (bp) segment of the 18S rRNA gene as previously described [7]. A standard curve 
was generated using human genomic DNA (Roche, Indianapolis,IN) ranging from 1 to 
10000 pg. An internal amplification control was carried out in a separate reaction to rule 
out inhibition of the PCR reaction as previously described [7].  
Fungal DNA was quantified using two broad-range fungal PCR assays using EvaGreen® 
(Biotium Inc, Hayward, CA), a fluorescent double stranded DNA binding dye. Dilutions of 
extracted genomic DNA from Candida albicans (ATCC 90028) and Aspergillus fumigatus 
(ATCC MYA-1163) ranging from 10 fg to 1000 pg were used for quantification of fungal 
DNA as described previously [6]. The ITS-2 (primers 5.8 forward and 1 reverse) assay 
amplifies a 210-290 bp segment of rRNA operon, the 28S (primers 10 forward and 12 
reverse) assay a 332-346 bp amplicon, depending on the fungal organism [8]. Fungal PCR 
assays were performed in duplicate. The median of duplicate PCR reactions was used for 
calculation. A positive fungal PCR was defined as an amplicon with the same peak melting 
temperature (±1°C) of the dissociation curve in both duplicates before a cycle threshold of 
40. 
No template controls were used to monitor contamination during PCR setup and in the 
master mix. Extraction-negative controls, consisting of water were processed in parallel 
with tissue samples to monitor for contamination during the extraction procedure.  
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Sequencing of amplicons: The amplicons of fungal PCR positive samples were 
sequenced using the primer 5.8S forward and 28S 10 forward. Etiologic agents were 
determined by comparison of the obtained sequences with an internal database as 
described previously [6]. For the identification of fungi at the species level, a similarity of 
more than 97% was required.    
 
Statistical analysis: The amount of human and fungal DNA amplified at extraction 
temperatures of 65°C and 90°C was compared using the Wilcoxon matched pairs signed 
rank test in GraphPad Prism (Graphpad Software Inc., LaJolla, CA, USA). A p-value below 
0.05 in a two sided test was considered significant. The mean of the relative changes in 
the amount of amplified DNA between 65° and 90° incubation temperature with 95% 
confidence intervals (CI) were calculated in GraphPad Prism. The median amount of 
fungal DNA of duplicate qPCR measurements at different durations of incubation at 90°C 
for both fungal PCR assays from two separate extractions is plotted versus the duration of 
incubation. Standard errors of the mean were calculated and plotted using GraphPad 




The sampled tissues are described in table 1. Histopathology documented fungal 
elements in the first and last slide of all included samples. Three samples showed yeast 
cells and septated mould hyphae were documented in five samples.  
 
The median amount of amplifiable human DNA, as detected by the 18S rRNA gene assay, 
increased from 722 pg at 65°C to 55428 pg/sample at 90°C incubation for one hour 
(p=0,008) or 76-fold (13-190; 95% CI) (figure 1).  
 
The broad-range fungal PCR assays detected fungal DNA in six (ITS-2-assay) and five 
(28S-assay) of the eight samples after incubation at 65°C for one hour (table 1). With the 
increased incubation temperature of 90°C, seven (ITS-2) and eight (28S) samples were 
positive for fungal DNA. The mean amount of fungal DNA in samples positive at both 
extraction temperatures increased from 0.53 to 32.74 pg/sample (p=0.02) as determined 
by the ITS-2 assay and from 0.13 to 18.07 (p=0.03) by the 28S assay (figure 1).  
 
Sequencing of the amplicons identified Aspergillus fumigatus in four samples and 
Aspergillus flavus, Candida albicans, Candida tropicals and Cryptococcus neoformans in 
one sample each (table 1). 
 
Increasing the duration of incubation at 90°C to three hours further increased the amount 
of amplifiable fungal DNA in all four samples tested (figure 2). While incubation for six 
hours was not detrimental to the amount recovered, further increase reduced the amount 
of amplifiable fungal DNA.  
 
All extraction controls were negative for fungal DNA. No inhibition was detected by the 
internal amplification control, suggesting that the improvements in the yield of amplifiable 






We used quantitative PCR to evaluate the effect of thermal energy on the extraction of 
DNA from FFPE tissue samples from patients with proven IFI. The amount of amplifiable 
human and fungal DNA significantly increased, leading to a superior identification of fungi 
by sequencing of the amplicons of broad-range fungal PCR assays.  
 
Improvements in the amount of amplifiable human DNA from FFPE tissue specimens due 
to the application of thermal energy have been reported previously by researchers using 
different extraction protocols. This suggests an underlying mechanism that is not 
dependent on the extraction protocol [5]. The absence of detectable PCR inhibition in our 
samples and a dose response effect with increasing incubation duration until three hours 
at 90°C argue that thermal energy may enhance the liberation of amplifiable DNA from 
FFPE tissue samples. A reversal of formalin induced crosslinking between DNA and 
proteins is suggested to be the underlying mechanism [5]. The different magnitude of 
increase seen with different samples may be explained by variations in the sample 
processing, such as the time a specimen is incubated in formalin or by different tissue to 
formalin ratios.  
 
Several factors impacting the extraction of fungal DNA from FFPE tissue specimens from 
patients with IFI have been described. First, the amplification of fungal DNA appears to 
differ between fungal pathogens. Whereas the amplification appears to be most successful 
from samples containing yeasts, samples containing moulds, especially the mucorales 
appear to do worse [6,10]. Our study includes samples from patients with the most 
common fungal pathogens, yeasts and moulds. The application of thermal energy appears 
to increase the amount of amplifiable fungal DNA from both. As we did not study samples 
from patients with mucormycosis, we do not know if DNA from these or other emerging 
fungal pathogens behaves differently. In a subsequent study, we used a protocol with 3 
hours of incubation at 90°C on a larger sample set. This allowed for the identification of 
fungal DNA from patients with invasive candidiasis in 10 of 11 cases, with septate mould 
infections in 8 of 10 cases, and with mucormycosis in 10 of 19 cases [6]. This compares 
favourably with previous studies using nested PCR assays or larger amounts of tissue to 
identify fungi from FFPE tissue samples [12,13]. Second, the amplicon length of the PCR 
assay may have an impact on the yield of amplifiable fungal DNA, as evidenced by a 
higher number of fungal DNA positive samples at 65°C using the ITS-2 assay with a 
shorter amplicon, and an increasing positivity of the 28S assay at 90°C, which produces 
longer amplicons that may be more sensitive to the effects of formalin fixation. This is in 
accordance with recent studies demonstrating superior amplification of shorter amplicons 
by fungal PCR assays from FFPE tissue specimens [9,10]. Third, different extraction 
protocols have been shown to vary in the efficiency of fungal DNA extraction. We used a 
non enzymatic extraction kit supplemented with additional steps to remove the paraffin 
and for mechanical lysis of fungal cells. While some commercial extraction kits designed 
for FFPE tissue samples may provide more convenient handling, adaptations of these kits 
for fungal DNA extraction require careful optimisation in terms of possible contaminations 
with fungal DNA, or inhibition of the PCR reaction which may adversely affect outcome 
[10]. The introduction of a heating step into such assays needs careful optimisation to 
avoid unintended consequences such as the attenuation of enzymatic lysis steps. In 
addition, increasing the amount of amplifiable human DNA in samples from patients with 
proven IFI may reduce the amplification of fungal DNA through dilution of relevant targets 
relative to non-relevant DNA, and through inhibition of PCR at the highest DNA 
concentrations [11]. By using broad-range primers designed to amplify fungal DNA in the 
presence of high levels of human DNA and screening for inhibition of the PCR reaction we 
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were able to increase the number of samples from which fungal DNA could be amplified 
and identified by sequencing [8].  
 
Improving the yield of fungal DNA extraction from FFPE tissue samples from patients with 
proven IFI may allow investigators to target lower copy number genes, such as 
determinants of acquired in vitro resistance and genes needed to distinguish between 
molecular siblings that share identical ribosomal RNA sequences but differ in in vitro 
resistance to antifungals. This information provides the potential to improve fungal 
diagnostics and improve our knowledge of the etiology and epidemiology of IFI. Data on 
species level identification of fungal pathogens will help allow targeting of antifungal 
therapy, leading to better patient outcomes. Furthermore, empiric use of antifungals needs 
to be driven by knowledge about the most common fungal pathogens in a clinical setting, 









Figure 1. Amount of DNA as detected by three quantitative PCR assays at different 
incubation temperatures. Open symbols represent samples from yeast infections (sample 
4:∆, sample 6: □, sample 2:○), closed symbols from mould infections (sample 1:▲, sample 











Figure 2. Amount of fungal DNA at different incubation times at 90°C incubation 
temperature as determined by two broadrange fungal PCR assays (left: ITS-2 assay, right: 
28S assay).  Open symbols represent samples from yeast infections (sample 4:∆, sample 
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